Co-Chairs: Murray Fingeret, OD, FAAO | Gregory K. Harmon, MD | Louis Pasquale, MD, FARVO
Moderator: Jeffrey M. Liebmann, MD
COPE CE Offered and Approved for AMA PRA Category 1 Credits™
Panel Discussions | Breakfast and Lunch
Agenda:
7:45am Breakfast
8:15am Welcome: Gregory K. Harmon, MD and Elena Sturman
8:20-9:50am Session 1 – Structure/Function: Murray Fingeret, OD, FAAO, Moderator – 90 minutes
Diagnosing Glaucoma with the OCT Alone: Donald C. Hood, PhD – 30 minutes
Clinical Advantages to 3D Reconstruction of the Optic Nerve Head and Peripapillary Tissue: Lucy Qing Shen, MD – 20 minutes
VR Perimetry – Is this the Future of Perimetry?: Vincent Michael Patella, OD, FAAO – 20 minutes
Panel Discussion: Alon Harris, MS, PhD, FARVO – 20 minutes
- Can an objective definition of glaucoma be widely accepted not only for research purposes but also clinical care?
- How early does glaucoma need to be diagnosed from a cost/benefit standpoint?
- Should the use of perimetry be limited to those cases in which OCT results are inconclusive?
9:50-10:10am Break
10:10-11:40am Session 2 – Artificial Intelligence and Glaucoma: Jeffrey M. Liebmann, MD, Moderator – 90 minutes
An Overview: Felipe Medeiros, MD, PhD – 30 minutes
Clinical Applicability of AI: Linda Zangwill, PhD – 30 minutes
Case Presentation and Panel Discussion: C. Gustavo De Moraes, MD, PhD, MPH – 30 minutes
- What are the main barriers that hinder AI from being ready for clinical use in glaucoma management in 2022-2023?
- How to enable data sharing across clinical centers and industry to accelerate AI development?
11:40am-12:00pm Break
12:00-1:30pm Session 3 – Hot Topics 90 Minutes: Louis Pasquale, MD, FARVO, Moderator – 90 minutes
Applying Genetics in Your Practice: Janey L. Wiggs, MD, PhD – 30 minutes
Restoring Vision in Glaucoma Patients - Optic Nerve Transplantation: Thomas V. Johnson III, MD, PhD – 30 minutes
Case Presentation and Panel Discussion: Alon Harris, MS, PhD, FARVO – 30 minutes
- When should clinicians refer patients for genetic testing for diseases with a Mendelian inheritance (eg: MYOC)? What to do if the test comes positive for the most common mutations?
- How to balance the potential for vision recovery in glaucoma and the need to manage risk factors that may continue to threaten vision even after those new therapies are performed?
1:30-2:30pm Lunch
Grantor Statement
This activity is supported by unrestricted medical education grants from AbbVie, Carl Zeiss Meditec, Glaukos, Heidelberg Engineering, New World Medical, Ora, Inc, Qlaris Bio, and Santen.
Accreditation & Designation Statements
Jointly provided by Evolve Medical Education and The Glaucoma Foundation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Glaucoma Foundation. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
Evolve designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Evolve Medical Education, LLC is a COPE-accredited administrator.
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
